No presumption of safety: FDA issues multiple warning letters to CBD firms
As it fired off warning letters to 15 companies for illegally selling cannabidiol-based products, the US Food and Drug Administration this week said there should be no presumption of safety…
Greater focus needed on vitamin D deficiency in younger healthy populations – researchers
UK researchers this week called for more awareness of vitamin D deficiency in younger healthy populations in the UK.
UK academic warns of antibiotic resistance risk from probiotic bacteria
A UK-based specialist in medical microbiology has warned of the risk that probiotic bacteria – found in some fermented foods and supplements – may confer resistance to antibiotics.
Blackmore’s new CEO wants company to ‘rejuvenate Australia business’
The new CEO at leading Australian supplements brand Blackmore’s says he wants the company ‘rejuvenate’ business activity in its home market.
Pioneering clean-tech extraction captures ‘peak freshness and purity’
Madrid-headquartered Pharmactive Biotech Products – maker of affron, the clean-label saffron extract – says that its new proprietary natural extraction process sets a “gold standard” in green technology.
FDA warning over ‘proliferation’ of CBD products making unlawful claims
The US Food & Drug Administration has reiterated its concerns over what is claims is “the proliferation” of CBD-containing products on the US market that are being unlawfully marketed for…
Trade groups call for ‘urgent clarity’ on CBD supplement status
Four US trade groups this week called on Congress to pass legislation clarifying that hemp-derived CBD is a lawful dietary ingredient if a supplement meets established safety and quality criteria.
UK watchdog faces challenge on decision to accredit homeopathy group
The Good Thinking Society, a UK charity that sets out to promote “rational scepticism”, is to challenge in court a decision by the Professional Standards Authority (PSA) to award accreditation to…
Germany’s Diapharm teams up with GMTCM Park in TCM cooperation
Münster, Germany-headquartered pharma consultancy Diapharm GmbH Co. & KG this week signed a cooperation agreement with Guangdong-Macau Traditional Chinese Medicine Technology Industrial Park Development Co., Ltd. (GMTCM Park)
Epax to invest $35 million in Omega-3 innovation
Norway-headquartered marine oil innovator Epax is investing $35 million over the next two years to increase its capacity and boost innovation in the Omega-3 sector.